Home
About
Leadership Team
Management Team
Scientific Advisory Board
Technology
Oncolytic Virus
B-Cell Peptide Cancer Vaccines
Mimotopes
Arginine Modulators
Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors
Announcements
Analyst Coverage
Annual Reports
Investor Presentations
Media
Videos
Newsletters
Blog
Governance
Corporate Governance
Share Trading Policies
Privacy Policy
Looking Forward Statement
Contact

Imugene (ASX: IMU)

Home
About
Leadership Team
Management Team
Scientific Advisory Board
Technology
Oncolytic Virus
B-Cell Peptide Cancer Vaccines
Mimotopes
Arginine Modulators
Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors
Announcements
Analyst Coverage
Annual Reports
Investor Presentations
Media
Videos
Newsletters
Blog
Governance
Corporate Governance
Share Trading Policies
Privacy Policy
Looking Forward Statement
Contact
Imugene199A8914.jpg

Management

  • About
  • Leadership Team
  • Management Team
  • Scientific Advisory Board
Dr Nick Ede | Chief Technology Officer
Dr Nick Ede | Chief Technology Officer
Dr Mark Marino | Chief Medical Officer
Dr Mark Marino | Chief Medical Officer
Dr Anthony Good | VP Clinical Research
Dr Anthony Good | VP Clinical Research
Previous: Leadership
Next: Scientific Advisory Board
Back to Top
Imugene Limited, 37 Bligh Street, Suite 1006, level 10, Sydney, NSW, 2000, Australia +61.3.9824.5254info@imugene.com

site by goodtrip